1-13 of 13
Mano Horinaka
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 5847: A histone deacetylase inhibitor OBP-801 and eribulin synergistically inhibit the growth with apoptosis in triple-negative breast cancer cells

Hisako Ono, Yoshihiro Sowa, Yosuke Iizumi, Mano Horinaka, Tetsuya Taguchi, Toshiyuki Sakai
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 5847.
https://doi.org/10.1158/1538-7445.AM2018-5847
Published: 01 July 2018
View article titled, Abstract 5847: A histone deacetylase inhibitor OBP-801 and eribulin synergistically inhibit the growth with apoptosis in triple-negative breast cancer cells
Journal Articles

Abstract 242: Anti-obesity drugorlistat enhances sensitivity toTRAIL by two different pathways inhormone-refractory prostate cancer cells

Jun Fujiwara, Yoshihiro Sowa, Mano Horinaka, Makoto Koyama, Miki Wakada, Tsuneharu Miki, Toshiyuki Sakai
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 242.
https://doi.org/10.1158/1538-7445.AM2012-242
Published: 15 April 2012
View article titled, Abstract 242: Anti-obesity drugorlistat enhances sensitivity toTRAIL by two different pathways inhormone-refractory prostate cancer cells
Journal Articles

Abstract 2695: Lactobacillus plantarum induces TRAIL production and facilitates natural killer activity against cancer cells

Mano Horinaka, Tatsushi Yoshida, Atsuko Kishi, Kaoru Akatani, Takashi Yasuda, Junji Kouhara, Miki Wakada, Toshiyuki Sakai
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): 2695.
https://doi.org/10.1158/1538-7445.AM2011-2695
Published: 15 April 2011
View article titled, Abstract 2695: Lactobacillus plantarum induces TRAIL production and facilitates natural killer activity against cancer cells
Journal Articles

Abstract 2560: Cyclin-dependent kinase inhibitor SU9516 enhances sensitivity to methotrexate in human T-cell Jurkat cells

Hitoji Uchiyama, Yoshihiro Sowa, Miki Wakada, Mayumi Yogosawa, Ryoko Nakanishi, Mano Horinaka, Chihiro Shimazaki, Masafumi Taniwaki, Toshiyuki Sakai
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 2560.
https://doi.org/10.1158/1538-7445.AM10-2560
Published: 15 April 2010
View article titled, Abstract 2560: Cyclin-dependent kinase inhibitor SU9516 enhances sensitivity to methotrexate in human T-cell Jurkat cells
Journal Articles

Abstract 5415: Histone deacetylase inhibitors and 15-deoxy-Δ12,14-prostaglandin J2 synergistically induce apoptosis

Makoto Koyama, Yasuyuki Izutani, Ahmed E. Goda, Taka-aki Matsui, Mano Horinaka, Mitsuhiro Tomosugi, Jun Fujiwara, Yoshitaka Nakamura, Miki Wakada, Shingo Yogosawa, Yoshihiro Sowa, Toshiyuki Sakai
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 5415.
https://doi.org/10.1158/1538-7445.AM10-5415
Published: 15 April 2010
View article titled, Abstract 5415: Histone deacetylase inhibitors and 15-deoxy-Δ<sup>12,14</sup>-prostaglandin J<sub>2</sub> synergistically induce apoptosis
Journal Articles

Abstract #5499: Overcoming TRAIL resistance by dipyridamole: A new role for an old drug

Ahmed Goda, Tatsushi Yoshida, Mano Horinaka, Takashi Yasuda, Takumi Shiraishi, Miki Wakada, Toshiyuki Sakai
Journal: Cancer Research
Cancer Res (2009) 69 (9_Supplement): 5499.
Published: 01 May 2009
View article titled, Abstract #5499: Overcoming TRAIL resistance by dipyridamole: A new role for an old drug
Journal Articles

Baicalein Overcomes Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Resistance via Two Different Cell-Specific Pathways in Cancer Cells but not in Normal Cells

Hiroya Taniguchi, Tatsushi Yoshida, Mano Horinaka, Takashi Yasuda, Ahmed E. Goda, Masako Konishi, Miki Wakada, Keisho Kataoka, Toshikazu Yoshikawa, Toshiyuki Sakai
Journal: Cancer Research
Cancer Res (2008) 68 (21): 8918–8927.
https://doi.org/10.1158/0008-5472.CAN-08-1120
Published: 30 October 2008
View article titled, Baicalein Overcomes Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Resistance via Two Different Cell-Specific Pathways in Cancer Cells but not in Normal Cells
Open the PDF for Baicalein Overcomes Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Resistance via Two Different Cell-Specific Pathways in Cancer Cells but not in Normal Cells in another window
Includes: Supplementary data
Journal Articles

Dietary flavonoid apigenin sensitizes malignant tumor cells to tumor necrosis factor-related apoptosis-inducing ligand

Mano Horinaka, Tatsushi Yoshida, Takumi Shiraishi, Susumu Nakata, Miki Wakada, Toshiyuki Sakai
Journal: Cancer Research
Cancer Res (2007) 67 (9_Supplement): 5134.
Published: 01 May 2007
View article titled, Dietary flavonoid apigenin sensitizes malignant tumor cells to tumor necrosis factor-related apoptosis-inducing ligand
Journal Articles

Luteolin induces death receptor 5 up-regulation and the combination of TRAIL and luteolin enhances apoptosis in human cervical cancer HeLa cells

Mano Horinaka, Tatsushi Yoshida, Takumi Shiraishi, Susumu Nakata, Miki Wakada, Ryoko Nakanishi, Hoyoku Nishino, Toshiyuki Sakai
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 177.
Published: 15 April 2006
View article titled, Luteolin induces death receptor 5 up-regulation and the combination of TRAIL and luteolin enhances apoptosis in human cervical cancer HeLa cells
Journal Articles

Tunicamycin Enhances Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand–Induced Apoptosis in Human Prostate Cancer Cells

Takumi Shiraishi, Tatsushi Yoshida, Susumu Nakata, Mano Horinaka, Miki Wakada, Yoichi Mizutani, Tsuneharu Miki, Toshiyuki Sakai
Journal: Cancer Research
Cancer Res (2005) 65 (14): 6364–6370.
https://doi.org/10.1158/0008-5472.CAN-05-0312
Published: 15 July 2005
View article titled, Tunicamycin Enhances Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand–Induced Apoptosis in Human Prostate Cancer Cells
Open the PDF for Tunicamycin Enhances Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand–Induced Apoptosis in Human Prostate Cancer Cells in another window
Journal Articles

Proteasome Inhibitor MG132 Induces Death Receptor 5 through CCAAT/Enhancer-Binding Protein Homologous Protein

Tatsushi Yoshida, Takumi Shiraishi, Susumu Nakata, Mano Horinaka, Miki Wakada, Yoichi Mizutani, Tsuneharu Miki, Toshiyuki Sakai
Journal: Cancer Research
Cancer Res (2005) 65 (13): 5662–5667.
https://doi.org/10.1158/0008-5472.CAN-05-0693
Published: 01 July 2005
View article titled, Proteasome Inhibitor MG132 Induces Death Receptor 5 through CCAAT/Enhancer-Binding Protein Homologous Protein
Open the PDF for Proteasome Inhibitor MG132 Induces Death Receptor 5 through CCAAT/Enhancer-Binding Protein Homologous Protein in another window
Journal Articles

Tunicamycin sensitizes TRAIL/Apo2L-induced apoptosis through up-regulation of death receptor 5/TRAIL-R2 in prostate cancer cells

Takumi Shiraishi, Tatsushi Yoshida, Susumu Nakata, Mano Horinaka, Miki Wakada, Yoichi Mizutani, Tsuneharu Miki, Toshiyuki Sakai
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 416.
Published: 01 May 2005
View article titled, Tunicamycin sensitizes TRAIL/Apo2L-induced apoptosis through up-regulation of death receptor 5/TRAIL-R2 in prostate cancer cells
Journal Articles

Histone deacetylase inhibitors induce death receptor 5/TRAIL-R2, and potentiate TRAIL-mediated apoptosis in human malignant tumor cells

Susumu Nakata, Tatsushi Yoshida, Mano Horinaka, Takumi Shiraishi, Miki Wakada, Toshiyuki Sakai
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 413.
Published: 01 May 2005
View article titled, Histone deacetylase inhibitors induce death receptor 5/TRAIL-R2, and potentiate TRAIL-mediated apoptosis in human malignant tumor cells